Savage, Jessica
The University of Sydney · Westmead Hospital · Berlin Institute of Health at Charité - Universitätsmedizin Berlin · Westmead Institute for Medical Research · Vertex Pharmaceuticals (United States) · Charité – Universitätsmedizin Berlin
3 papers on CoChat
Most cited papers
- Verified
Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele
Middleton, P. G., Mall, M. A., Dřevínek, P., Lands, L. C., McKone, E. F., Polineni, D., Ramsey, B. W., Taylor-Cousar, J. L., Tullis, E., Vermeulen, F., et al. (2019) · New England Journal of Medicine
Cystic Fibrosis Research AdvancesInhalation and Respiratory Drug Delivery
Cited by 2,198
- Verified
VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles
Keating, D., Marigowda, G., Burr, L., Daines, C., Mall, M. A., McKone, E. F., Ramsey, B. W., Rowe, S. M., Sass, L. A., Tullis, E., et al. (2018) · New England Journal of Medicine
Cystic Fibrosis Research AdvancesInhalation and Respiratory Drug Delivery
Cited by 726
- Verified
Clinical development of triple-combination CFTR modulators for cystic fibrosis patients with one or two F508del alleles
Taylor-Cousar, J. L., Mall, M. A., Ramsey, B. W., McKone, E. F., Tullis, E., Marigowda, G., McKee, C. M., Waltz, D., Moskowitz, S. M., Savage, J., et al. (2019) · ERJ Open Research
Cystic Fibrosis Research AdvancesInhalation and Respiratory Drug Delivery
Cited by 105
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free